Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd

Bullboard Posts

Post by myllow1on Dec 13, 2006 9:33pm

186 Views

Post# 11864065

Current SP action

The current action makes me think the other assay results for the Marban mine are probably closed, most likely a question of days... Also, the Kierens et Norlartic drill results might be in the pipeline as well. These will be interesting and will confirm previous Aur Resources values and estimates... Not holding my breath, however the next results shall move us well above the 0.30 line... GLTA MY1

Bullboard Posts

Unique Battery Metals opportunity in Quebec